StockNews.com Downgrades Select Medical (NYSE:SEM) to Hold

Select Medical (NYSE:SEM) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Tuesday.

A number of other analysts have also recently weighed in on the company. Bank of America initiated coverage on Select Medical in a research report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective for the company. Royal Bank of Canada lifted their price target on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday. Finally, Benchmark reaffirmed a “buy” rating and set a $48.00 price target on shares of Select Medical in a research report on Friday, November 1st. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $40.75.

Select Medical Trading Up 3.0 %

Shares of NYSE:SEM opened at $38.34 on Tuesday. Select Medical has a 12-month low of $21.56 and a 12-month high of $40.50. The business’s fifty day simple moving average is $34.36 and its 200-day simple moving average is $34.24. The company has a market capitalization of $4.96 billion, a PE ratio of 17.92, a P/E/G ratio of 1.90 and a beta of 1.42. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period last year, the business posted $0.46 EPS. The business’s revenue was up 5.7% compared to the same quarter last year. As a group, equities research analysts predict that Select Medical will post 2.16 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Select Medical

A number of institutional investors have recently modified their holdings of SEM. Vanguard Group Inc. raised its stake in shares of Select Medical by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock valued at $391,886,000 after buying an additional 650,093 shares during the last quarter. Point72 Asset Management L.P. increased its stake in shares of Select Medical by 179.5% in the 2nd quarter. Point72 Asset Management L.P. now owns 843,528 shares of the health services provider’s stock valued at $29,574,000 after purchasing an additional 541,728 shares in the last quarter. Millennium Management LLC increased its stake in shares of Select Medical by 183.9% in the 2nd quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock valued at $23,824,000 after purchasing an additional 440,140 shares in the last quarter. Hood River Capital Management LLC purchased a new position in shares of Select Medical in the 2nd quarter valued at about $14,819,000. Finally, Ceredex Value Advisors LLC purchased a new position in shares of Select Medical in the 2nd quarter valued at about $11,456,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.